The Impact of SARS Epidemic on Firm Investment: Evidence from Listed Firms in China

Jinyong Zhan, Zixie Zhang and Mingjie Rui

Emerging Markets Finance and Trade, 2025, vol. 61, issue 4, 1095-1112

Abstract: The outbreak of SARS in 2003 brought a great shock to China’s socio-economic development, but empirical studies on its long-term economic impact are relatively scarce. We use the outbreak of SARS as a quasi-natural experiment, employing city-level case data and listed firm data to study the impact of the pandemic on fixed investment. Compared with cities without SARS cases, firms in cities with SARS cases significantly increased their fixed investment by 26.4%. After conducting a series of endogeneity tests, represented by PSM-DID, our conclusions remain robust. Credit conditions in the affected cities were relaxed after the epidemic. This shift led to a notable decrease in firms’ financial constraints and burdens, thereby offering substantial financing support for fixed investments. To offset the losses endured during the epidemic, firms bolster their investment in high-risk projects. The results of our heterogeneity analysis also support the two mechanisms.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/1540496X.2024.2407978 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mes:emfitr:v:61:y:2025:i:4:p:1095-1112

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/MREE20

DOI: 10.1080/1540496X.2024.2407978

Access Statistics for this article

More articles in Emerging Markets Finance and Trade from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().